Abeona Therapeutics
ABEO
Abeona Therapeutics (ABEO) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Maintained | Overweight | $30.00 from $28.00 | Sep 18, 2026 |
| Roth Capital | Initiated Coverage | Buy | $17.00 | Sep 17, 2026 |
| Oppenheimer | Maintained | Outperform | $21.00 from $22.00 | Aug 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | May 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Mar 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Mar 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Oct 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Aug 18, 2025 |
| Oppenheimer | Maintained | Outperform | $20.00 from $19.00 | Aug 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Jul 16, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Jul 14, 2025 |
| Oppenheimer | Initiated Coverage | Outperform | $19.00 | Jun 2, 2025 |
| Stifel | Maintained | Buy | $20.00 from $21.00 | May 16, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $15.00 | Apr 30, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Mar 24, 2025 |
| Oppenheimer | Initiated Coverage | Outperform | $16.00 | Mar 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Feb 19, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Nov 25, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Oct 31, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | $18.00 | Oct 29, 2024 |
Frequently asked questions
What is the latest analyst rating on ABEO?
On Sep 18, 2026, Cantor Fitzgerald maintained Abeona Therapeutics at Overweight with a price target of $30.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.